Add to ORKGBackground: The prevalence of transmitted HIV drug resistance (TDR) is stabilizing or decreasing in developed countries. However, this trend is not specifically evaluated among immigrants from regions without well-implemented antiretroviral strategies. Methods: TDR trends during 1996–2010 were analyzed among naı̈ve HIV-infected patients in Spain, considering their origin and other factors. TDR mutations were defined according to the World Health Organization list
Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may contribut...
Our objectives were to carry out an epidemiological surveillance study on transmitted drug resistanc...
<div><p>Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may c...
The prevalence of transmitted HIV drug resistance (TDR) is stabilizing or decreasing in developed co...
Most of the non-B HIV-1 subtypes are predominant in Sub-Saharan Africa and India although they have ...
Objective: To study the trends of transmitted drug resistance (TDR) in HIV-1 patients newly diagnose...
AbstractWe have studied transmitted drug resistance (TDR) in 1.864 antiretroviral-naïve patients ent...
Transmitted drug resistance (TDR) remains an important concern for the management of HIV infection, ...
Background: Transmitted drug resistance (TDR) remains an important concern for the management of HIV...
To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with ...
BACKGROUND: In Europe, a continuous programme (SPREAD) has been in place for ten years to study tran...
Background In Europe, a continuous programme (SPREAD) has been in place for ten years to study tran...
OBJECTIVES: To evaluate the prevalence of transmitted drug resistance (TDR) and non-...
<p>Asterisks indicate that the frequency of TDR to NRTIs from 10% in 2004 to 2% in 2012 was statisti...
Migration is associated with HIV-1 vulnerability. OBJECTIVES: To identify long-term trends in HIV-1 ...
Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may contribut...
Our objectives were to carry out an epidemiological surveillance study on transmitted drug resistanc...
<div><p>Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may c...
The prevalence of transmitted HIV drug resistance (TDR) is stabilizing or decreasing in developed co...
Most of the non-B HIV-1 subtypes are predominant in Sub-Saharan Africa and India although they have ...
Objective: To study the trends of transmitted drug resistance (TDR) in HIV-1 patients newly diagnose...
AbstractWe have studied transmitted drug resistance (TDR) in 1.864 antiretroviral-naïve patients ent...
Transmitted drug resistance (TDR) remains an important concern for the management of HIV infection, ...
Background: Transmitted drug resistance (TDR) remains an important concern for the management of HIV...
To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with ...
BACKGROUND: In Europe, a continuous programme (SPREAD) has been in place for ten years to study tran...
Background In Europe, a continuous programme (SPREAD) has been in place for ten years to study tran...
OBJECTIVES: To evaluate the prevalence of transmitted drug resistance (TDR) and non-...
<p>Asterisks indicate that the frequency of TDR to NRTIs from 10% in 2004 to 2% in 2012 was statisti...
Migration is associated with HIV-1 vulnerability. OBJECTIVES: To identify long-term trends in HIV-1 ...
Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may contribut...
Our objectives were to carry out an epidemiological surveillance study on transmitted drug resistanc...
<div><p>Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may c...